Home › NDC Lookup › RxCUI directory › RxCUI 311726

Mirtazapine 45 MG Oral Tablet — RxCUI 311726

RxNorm drug concept · Semantic clinical drug
RxCUI 311726 Semantic clinical drug · SCD ● Current RxNorm concept 50 FDA products 136 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311726
Official nameMirtazapine 45 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped50
Package NDCs mapped136
Reported Medicaid activity (SDUD)2,621,699 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mirtazapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats major depressive disorder (MDD) in adults. It's an antidepressant that may raise norepinephrine and serotonin activity in the brain. Your prescriber will check over time...
  • Most people take it once a day, preferably in the evening before bed, since it commonly causes sleepiness. Food doesn't change how well it's absorbed. Follow your prescriber's dire...
  • When should I take it, and does food matter?
  • Sleepiness is the big one, along with dry mouth, increased appetite, weight gain, constipation, and dizziness. Be careful driving until you know how it affects you. Call your docto...
📖 Read our full Mirtazapine guide →

🕸️ Concept Web — How Mirtazapine 45 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mirtazapine 45 MG Oral Tablet RxCUI 311726

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mirtazapine 15996
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mirtazapine Oral Tablet 378384
    • Mirtazapine Oral Product 1165364
    • Mirtazapine Pill 1165365
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Mirtazapine 45 MG 343213

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mirtazapine 45 MG SCDC · 343213
  • Mirtazapine Oral Tablet SCDF · 378384
  • Mirtazapine Oral Product SCDG · 1165364
  • Mirtazapine Pill SCDG · 1165365

📦 FDA Products & Package NDCs

50 products · 136 package NDCs
136 package NDCs map to RxCUI 311726 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-3515-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3515-01) Mirtazapine Mylan Pharmaceuticals Inc. 2016-08-02
00378-3515-10 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3515-10) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
00378-3515-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3515-93) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
00378-3530-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3530-01) Mirtazapine Mylan Pharmaceuticals Inc. 2016-08-02
00378-3530-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3530-05) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
00378-3530-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3530-93) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
00378-3545-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3545-01) Mirtazapine Mylan Pharmaceuticals Inc. 2016-08-02
00378-3545-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3545-05) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
00378-3545-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3545-93) Mirtazapine Mylan Pharmaceuticals Inc. 2003-06-20
13107-0001-01 100 TABLET, FILM COATED in 1 BOTTLE (13107-001-01) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0001-05 500 TABLET, FILM COATED in 1 BOTTLE (13107-001-05) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0001-30 30 TABLET, FILM COATED in 1 BOTTLE (13107-001-30) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0001-60 60 TABLET, FILM COATED in 1 BOTTLE (13107-001-60) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0001-90 90 TABLET, FILM COATED in 1 BOTTLE (13107-001-90) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-01 100 TABLET, FILM COATED in 1 BOTTLE (13107-003-01) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-05 500 TABLET, FILM COATED in 1 BOTTLE (13107-003-05) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-30 30 TABLET, FILM COATED in 1 BOTTLE (13107-003-30) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-32 30 TABLET, FILM COATED in 1 BLISTER PACK (13107-003-32) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-34 30 TABLET, FILM COATED in 1 BOTTLE (13107-003-34) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-60 60 TABLET, FILM COATED in 1 BOTTLE (13107-003-60) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0003-90 90 TABLET, FILM COATED in 1 BOTTLE (13107-003-90) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-01 100 TABLET, FILM COATED in 1 BOTTLE (13107-031-01) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-05 500 TABLET, FILM COATED in 1 BOTTLE (13107-031-05) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-30 30 TABLET, FILM COATED in 1 BOTTLE (13107-031-30) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-32 30 TABLET, FILM COATED in 1 BLISTER PACK (13107-031-32) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-34 30 TABLET, FILM COATED in 1 BOTTLE (13107-031-34) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-60 60 TABLET, FILM COATED in 1 BOTTLE (13107-031-60) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0031-90 90 TABLET, FILM COATED in 1 BOTTLE (13107-031-90) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-01 100 TABLET, FILM COATED in 1 BOTTLE (13107-032-01) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-05 500 TABLET, FILM COATED in 1 BOTTLE (13107-032-05) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-32 30 TABLET, FILM COATED in 1 BLISTER PACK (13107-032-32) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-34 30 TABLET, FILM COATED in 1 BOTTLE (13107-032-34) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-60 60 TABLET, FILM COATED in 1 BOTTLE (13107-032-60) Mirtazapine Aurolife Pharma LLC 2009-08-17
13107-0032-90 90 TABLET, FILM COATED in 1 BOTTLE (13107-032-90) Mirtazapine Aurolife Pharma LLC 2009-08-17
31722-0407-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-407-05) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0407-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-407-30) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0408-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-408-05) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0408-10 1000 TABLET, FILM COATED in 1 BOTTLE (31722-408-10) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0408-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-408-30) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0409-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-409-05) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0409-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-409-30) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0410-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-410-05) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
31722-0410-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-410-30) mirtazapine Camber Pharmaceuticals, Inc. 2025-10-02
48433-0076-20 100 BLISTER PACK in 1 CARTON (48433-076-20) / 1 TABLET, FIL... Mirtazapine Safecor Health LLC 2026-02-05
48433-0077-20 100 BLISTER PACK in 1 CARTON (48433-077-20) / 1 TABLET, FIL... Mirtazapine Safecor Health LLC 2026-02-05
48433-0078-20 100 BLISTER PACK in 1 CARTON (48433-078-20) / 1 TABLET, FIL... Mirtazapine Safecor Health LLC 2026-02-05
51079-0086-20 100 BLISTER PACK in 1 CARTON (51079-086-20) / 1 TABLET, FIL... Mirtazapine Mylan Institutional Inc. 2003-08-01
51079-0087-20 100 BLISTER PACK in 1 CARTON (51079-087-20) / 1 TABLET, FIL... Mirtazapine Mylan Institutional Inc. 2003-08-01
51079-0088-20 100 BLISTER PACK in 1 CARTON (51079-088-20) / 1 TABLET, FIL... Mirtazapine Mylan Institutional Inc. 2003-08-01
51407-0350-10 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-350-10) Mirtazapine Golden State Medical Supply, Inc. 2020-02-21
Observed labelers: Aurolife Pharma LLC (25) · Aurobindo Pharma Limited (23) · Apotex Corp. (12) · Camber Pharmaceuticals, Inc. (9) · Mylan Pharmaceuticals Inc. (9) · Bryant Ranch Prepack (8) · +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.